ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal

November 4, 1983

ASCO, AACR Hold Last Joint annual Meeting, Vow to Encourage Basic-Clinical Interaction

May 28, 1993

Cancer death rate dropping 1.1 percent a year, annual report finds.

October 7, 2005

DCBD Board Like Organ Systems Program But Not RFAs, Okays Program Announcement, Contract Concepts

November 20, 1987

In Brief: Peter Vogt Names Bristol-Myers Winner; Other Awards: Koop, Weinberg, Wynder, Longmire

March 24, 1989